ZENTALIS PHARMACEUTICALS INC. - COMMON STOCK

2,4300

14-февраля-25 16:45:00

15 мин. задержка

Акции

0,0000

0,00%

Сегодняшний диапазон

2,3900 - 2,5750

ISIN

N/A

Источник

NASDAQ

Zentalis Pharmaceuticals to Present at TD Cowen 5th Annual Oncology Innovation Summit

14 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress

07 май 2024 07:00:01 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 май 2024 17:30:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024

02 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 апр 2024 17:30:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 мар 2024 18:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

28 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates

27 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals to Participate in the Oppenheimer Healthcare Life Sciences Conference

13 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 фев 2024 17:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

25 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 янв 2024 16:49:03 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 дек 2023 17:39:15 Источник Nasdaq GlobeNewswire
Zentalis to Participate in Investor Call Focused on Ovarian Cancer with Gynecologic Oncology Key Opinion Leader Joyce F. Liu, M.D., MPH, Hosted by TD Cowen

09 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates

06 ноя 2023 07:18:31 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 ноя 2023 16:52:14 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 окт 2023 16:27:36 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference

06 сен 2023 07:00:01 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 сен 2023 16:37:58 Источник Nasdaq GlobeNewswire
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates

09 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.